ArticleJournal of cardiovascular development and disease2025
The Effects of Inclisiran on the Subclinical Prothrombotic and Platelet Activation Markers in Patients at High Cardiovascular Risk.
Mateusz Maligłówka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.